Telus Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-4.4%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
$0.37next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Free Cash Flow Quarterly583M
Net Debt-to-EBITDA Ratio Quarterly350.0%Target: 3.3x or lower by year-end 2026; 3.0x or better by year-end 2027
Total Customer Net Additions Quarterly262K
TELUS Health Lives Covered Quarterly170M
Research as of 2 Sep 2026